Neurotransmitter Balance: A Nutrition and Natural-Health Reference
1. Definition and Conceptual Framework
Neurotransmitters are endogenous chemicals that allow neurons to communicate with each other throughout the body, enabling the brain to provide a variety of functions through the process of chemical synaptic transmission. Through synaptic transmission, the central nervous system (CNS) can control smooth, skeletal, and cardiac muscles, bodily secretions, and organ functions. An essential role in information transmission throughout the CNS and peripheral nervous system is played by neurotransmitters, which are endogenous chemical messengers that carry and amplify nerve-to-nerve signaling or signals between nerves and other cell types.
Generally, there are no scientifically established "norms" for appropriate levels or "balances" of different neurotransmitters. In most cases, it is practically impossible to measure neurotransmitter levels in the brain or body at any given moment. The concept of "neurotransmitter balance" therefore refers broadly to the dynamic, relative equilibrium among excitatory and inhibitory signaling molecules that underpins healthy neurological and psychological function, rather than to a fixed, measurable set-point.
Neurotransmitter-related disorders occur when the current levels of neurotransmitters are unable to properly relay the electrical signal from one nerve cell to the next. A neurotransmitter imbalance can result from the quantity levels being either too high or too low. Neurotransmitters quantitatively exist in a delicate balance with one another in vivo. If the levels of one or more neurotransmitters become too low, the dynamic balance in vivo can shift and other neurotransmitter levels can become too high.
2. Major Neurotransmitters and Their Roles
The most widely studied neurotransmitters in the context of nutrition and natural health include the following:
- Serotonin (5-HT): Serotonin is a critical monoamine neurotransmitter and hormone that orchestrates a vast array of physiological and psychological processes, including mood, sleep, appetite, and gastrointestinal motility. The vast majority of serotonin (~95%) in the body is produced by enterochromaffin cells of the gut.
- Dopamine: Dopamine controls motivation, reward, movement, and emotional responses.
- GABA (Gamma-Aminobutyric Acid): GABA is the most important inhibitory neurotransmitter in the human brain cortex. It is an amino acid synthesized in the brain, playing an essential role as a neurotransmitter; its functions include decreasing the activity of neurons, supporting relaxation, reducing stress, stabilizing mood, decreasing pain, and improving sleep.
- Glutamate: Glutamate is the main excitatory neurotransmitter, essential for learning and memory.
- Norepinephrine: Norepinephrine is involved in stress responses, attention, and alertness.
- Acetylcholine: Choline is a precursor for the neurotransmitter acetylcholine. Acetylcholine is an excitatory neurotransmitter that plays a role in regulating sleep cycles and muscle functioning and contraction, as well as learning, memory, and attention. It also affects the central and peripheral nervous systems.
3. Body Systems Involved
The central nervous system processes information from and delivers information to the peripheral nervous system through signal conduction from one neuron to another via synapses. Through synaptic transmission, the CNS can control smooth, skeletal, and cardiac muscles, bodily secretions, and organ functions.
The enteric nervous system is intimately involved: research into the "second brain" (the enteric nervous system) is currently one of the most active areas of neuroscience, offering new insights into treating both gastrointestinal disorders and anxiety. The gut microbiota — the trillions of bacteria that reside within the gastrointestinal tract — has been found to not only be an essential component of immune and metabolic health, but also seems to influence development and diseases of the enteric and central nervous system, including motility disorders, behavioral disorders, neurodegenerative disease, cerebrovascular accidents, and neuroimmune-mediated disorders.
The hypothalamic-pituitary-adrenal (HPA) axis is also closely linked: magnesium influences activity of the hypothalamic-pituitary-adrenal axis, which instigates various responses to cope with stress demands, and also reduces central adrenocorticotrophic hormone and peripheral (cortisol) endocrine responses, thereby decreasing anxiety.
4. How Neurotransmitter Imbalance Presents
Significant imbalances or disruptions in neurotransmitter systems are associated with various diseases and mental disorders, including Parkinson's disease, depression, insomnia, attention deficit hyperactivity disorder (ADHD), anxiety, memory loss, dramatic weight changes, and addictions.
Symptoms of neurotransmitter imbalance can include mood changes (such as depression or anxiety), sleep disturbances, fatigue, concentration issues, appetite changes, and physical symptoms like headaches. More specifically, the presentation varies by which neurotransmitter system is affected:
- An excess of dopamine in some areas of the brain has been linked to schizophrenia. On the other hand, deficiency in dopamine can cause feelings of fatigue, low motivation, and difficulty experiencing pleasure.
- Low levels of serotonin often lead to conditions like depression and anxiety. This serotonin and depression link has driven research into medications like SSRIs (Selective Serotonin Reuptake Inhibitors) to rebalance serotonin levels.
- Alterations in the levels of specific neurotransmitters have been observed in various neurological disorders, including Parkinson's disease, schizophrenia, depression, and Alzheimer's disease.
Neurotransmitter imbalance is diagnosed through a combination of clinical assessments, symptom evaluations, and often laboratory tests, such as blood, urine, or cerebrospinal fluid analyses. Psychological assessments and patient history are also key in identifying imbalances, as there is currently no definitive test solely for neurotransmitter levels.
5. Contributing and Associated Factors
5.1 Chronic Stress
Chronic stress is typically the primary contributor to neurotransmitter imbalance in vivo. Stress, both emotional and physical, can cause neurons to use up large amounts of neurotransmitters in order to help the person cope with their problems. Chronic daily stresses — varying from a busy career, to a stressed personal relationship, to a bacterial or viral infection — will tax the nervous system and, over time, deplete neurotransmitter quantities.
5.2 Dietary Insufficiency
Poor dietary habits often lead to nervous system imbalances in vivo, especially if the poor diet is combined with high stress. The body must synthesize the majority of its neurotransmitters from nutrients, primarily amino acids and proteins, which are obtained in the diet or through dietary supplements.
5.3 Genetics
Of the many factors affecting neurotransmitter balance in vivo, four causes stand out as the most prevalent: (i) chronic stress; (ii) poor diet; (iii) neurotoxins; and (iv) human genetics. Genetic variations can alter the expression or efficiency of enzymes involved in neurotransmitter synthesis and metabolism, shifting individual biochemical set-points.
5.4 Gut Microbiome Dysbiosis
Dysbiosis of the gut microbiome can impact tryptophan metabolism and serotonin availability, contributing to neuropsychiatric disorders like depression. Recent studies show that the metabolites produced by the gut microbiota also include neurotransmitters such as glutamate, GABA, serotonin, and dopamine. Moreover, some bacteria encode genes for specific enzymes that can catalyze the conversion of substrates into corresponding neurotransmitters or precursors.
5.5 Substance Use and Medications
Drugs and alcohol disrupt neurotransmitter systems and can worsen imbalances. Some conditions are also related to neurotransmitter switching, a phenomenon where neurons change the type of neurotransmitters they release.
5.6 Aging
Age-related changes in the brain include neurotransmitter abnormalities, such as in serotonin, dopamine, receptor binding, and acetylcholine synthesis, which are often accompanied by cognitive decline, particularly in executive functions.
6. Nutritional Precursors and Cofactors
6.1 Amino Acid Precursors
Tryptophan
Serotonin synthesis is dependent on the availability of its dietary precursor, the essential amino acid tryptophan. The ability to change the rates of serotonin synthesis in the brain by manipulating concentrations of serum tryptophan is the foundation of much research. As the sole precursor of serotonin, experimental research has shown that L-tryptophan's role in brain serotonin synthesis is an important factor involved in mood, behavior, and cognition. It is estimated that only 1% of dietary tryptophan is used for serotonin synthesis in the brain, but despite the relatively low concentration of brain serotonin, it has a broad impact as a neurotransmitter and neuromodulator and has been implicated in numerous psychiatric conditions and psychological processes.
Tryptophan also feeds multiple metabolic pathways. The main metabolic pathway of tryptophan is oxidation to bioactive kynurenines and niacin. Kynurenic acid is the most potent endogenous anti-excitotoxic agent. Additionally, tryptophan serves as a precursor for de novo synthesis of vitamin B3 (niacin) via the kynurenine pathway.
Scientific evidence: Clinical and preclinical studies have used the tryptophan depletion model to investigate the idea that low serotonin synthesis is associated with depressed mood. Tryptophan depletion studies in never-depressed individuals are variable, with no or little overall effect on lowering of mood. Reports of moderate mood lowering are seen more often in studies with healthy women than in studies with healthy men. Overall evidence quality in humans is preliminary and mixed.
Tyrosine
Most neurotransmitter precursors are amino acids (e.g., tyrosine and tryptophan) derived from the diet, which enter the blood, are transported across the blood-brain barrier, and are taken up by corresponding neurotransmitter-producing cells. Tyrosine is the dietary precursor for dopamine, norepinephrine, and epinephrine (catecholamines).
Choline
The body uses choline to produce acetylcholine, which is one of the reasons it plays a role in various mental processes, such as memory and cognition.
6.2 5-Hydroxytryptophan (5-HTP)
5-Hydroxytryptophan is extracted from the seed of Griffonia simplicifolia, a climbing vine found in west and central Africa. 5-HTP is a naturally occurring amino acid and chemical precursor, as well as a metabolic intermediate in the biosynthesis of the neurotransmitter serotonin.
Scientific evidence: 5-HTP has been studied in different settings of acute anxiety and shown to significantly reduce the reaction to panic challenge in patients with panic disorders. In patients diagnosed with anxiety disorders, 5-HTP has been shown to lead to a moderate reduction of symptoms. There is some evidence in clinical studies for the treatment of depression; however, the quality and size of studies are limited. Overall, the clinical evidence base for 5-HTP remains preliminary.
6.3 B Vitamins
In addition to various amino acids, several B vitamins, including thiamin, riboflavin, niacin, vitamin B6, folate, and vitamin B12, are needed as cofactors for the synthesis of neurotransmitters.
Vitamin B6 (Pyridoxine): Pyridoxine plays an important role in numerous physiological processes. It acts as a cofactor in over 100 enzymatic reactions, including in the synthesis of neurotransmitters such as GABA, serotonin, and dopamine. In addition to modulating neurobiological mechanisms associated with mood disorders such as depression and anxiety, vitamin B6 may have other stress-reducing properties, including hypotensive effects and may reduce the physiological consequences of corticosteroid release.
Folate (B9) and B12: Vitamin B9 enables cerebral methylation processes, affecting the metabolism of the neurotransmitters serotonin and dopamine, which are important in mood regulation. More precisely, folate has been linked to the maintenance of adequate cerebral levels of tetrahydropterin, a key cofactor in the hydroxylation reactions that lead to the synthesis of serotonin and catecholamines.
GABA synthesis and B6: The synthesis of neurotransmitters, including glutamate and GABA, is also catalyzed by enzymes that require vitamin B6 as cofactors.
6.4 Magnesium
Magnesium is an enzymatic cofactor in over 600 biochemical reactions, and magnesium deficiency could affect allostatic regulation in multiple ways. Insufficient magnesium can affect the activity of glutamate decarboxylase, a cofactor for vitamin B6, leading to the conversion of the excitatory neurotransmitter glutamate into the inhibitory neurotransmitter GABA, potentially exacerbating symptoms of anxiety and other neuropsychiatric disorders. Therefore, adequate intake of vitamin B6 and magnesium is essential for maintaining normal nervous system function and overall health.
6.5 Zinc
The mineral zinc is important for proper function of GABA, aspartate, and norepinephrine. The minerals calcium, magnesium, and zinc are required as cofactors for numerous vitamin-dependent enzymes and also play a direct and crucial role in membrane excitability and neurotransmission. With the exception of calcium, none of these micronutrients is stored in the body in significant quantities and it is therefore essential that daily consumption is adequate.
6.6 Vitamin C
Vitamin C is required for synthesis of norepinephrine. Brain vitamin C is known to interact synergistically with B complex vitamins in the maintenance of several aspects of cognitive function and performance.
6.7 Omega-3 Fatty Acids
Evidence suggests that inadequate levels of n-3 (omega-3) polyunsaturated fatty acids (PUFA) in the brain may represent a risk factor for neuropsychiatric disorders. These fatty acids, which are derived from the diet, are a major component of neuronal membranes and are of particular importance in brain development and function. Low levels of n-3 PUFAs in the brain affect the brain dopamine systems and, when combined with appropriate genetic and other factors, increase the risk of developing these disorders and/or the severity of the disease.
Scientific evidence: A 2025 randomized controlled trial (30 physically active male participants randomly assigned to an omega-3 + resistance training group or a resistance training–only control group; the experimental group received 3,150 mg/day of omega-3 fatty acids (EPA and DHA) over eight weeks) found that increases in BDNF, dopamine, and serotonin levels revealed that this fatty acid contributes to synaptic plasticity and neurotransmitter balance. The study involved a small, exclusively male population and combined supplementation with exercise, limiting generalizability.
7. Herbs and Plant-Based Ingredients
7.1 St. John's Wort (Hypericum perforatum)
Traditional use: St. John's Wort (Hypericum perforatum) extract has been used for centuries to treat a number of disorders and is now available as an over-the-counter compound widely used to treat mild to moderate depression.
Scientific evidence: St. John's Wort extract has a clear inhibitory effect on the neuronal uptake not only of serotonin, noradrenaline, and dopamine but also of GABA and L-glutamate. No other antidepressant shows an approximately equally broad inhibitory profile. Standardized St. John's Wort extracts such as WS® 5570, WS® 5572, and LI 160 have proven effective in managing mild to severe major depression across 38 clinical trials and two meta-analyses. Post-marketing surveillance involving 34,804 patients showed a low incidence of adverse events (0–6%), with large-scale studies reporting only 0.1–2.4% adverse event rates and significantly lower dropout rates compared to synthetic antidepressants. While studies of depression have reported benefit in anxiety symptom reduction, there is limited evidence to support the use of St. John's Wort for the primary treatment of anxiety disorders. The evidence in mild-to-moderate depression is considered moderate to strong; evidence for broader neurotransmitter-related conditions remains limited.
7.2 Saffron (Crocus sativus)
Traditional use: Saffron, the stigmas of Crocus sativus L., has been mentioned extensively in traditional reference texts as a herbal medicine. It has been used historically in Persian, Ayurvedic, and Mediterranean healing traditions for mood-related conditions.
Scientific evidence: The active constituents crocin and safranal influence mood by modulating central neurotransmitters such as serotonin, dopamine, and norepinephrine. Saffron has been shown to inhibit serotonin reuptake and increase levels of these neurotransmitters in animal models, producing antidepressant effects comparable to fluoxetine. These findings are consistent with clinical trials demonstrating saffron's non-inferiority to SSRIs in mild-to-moderate depression. Clinical trials suggest that the effectiveness of saffron in treating mild to moderate depression is comparable to that of standard medications, and animal studies support these results, showing behavioral improvements with saffron treatment. Saffron is particularly appealing due to its safety and lower incidence of side effects. Despite encouraging clinical and mechanistic findings, saffron remains underutilized in clinical practice. Challenges include the lack of long-term safety data, standardization difficulties, variability in extract composition, and limited regulatory oversight.
7.3 Ashwagandha (Withania somnifera)
Traditional use: Withania somnifera (Solanaceae), commonly referred to as Indian ginseng or ashwagandha, has been used for thousands of years as a rejuvenating and revitalising herbal medication. It is central to Ayurvedic medicine as an adaptogen (rasayana) used for stress, fatigue, and cognitive support.
Scientific evidence: It is not entirely clear how ashwagandha exerts its action; partly, it may be due to its antioxidant activity, but it can also be due to its GABAergic activity. GABA is an inhibitory neurotransmitter whose function is to decrease neuronal function and prevent overexcitation. The GABAergic activity of W. somnifera on GABA-A and GABA-ρ1 ionotropic receptors could explain its efficacy in the treatment of insomnia. Studies suggest that it contains an ingredient with GABA-mimetic action. A randomized, double-blind, controlled clinical trial studying its efficacy on different parameters revealed a significant decrease in Hamilton Anxiety Rating Scale scores in the experimental group after 10 weeks of treatment. The overall clinical evidence is preliminary but growing, with most trials being small and short in duration.
7.4 Valerian (Valeriana officinalis)
Traditional use: Valeriana officinalis has been used since antiquity in European herbal traditions for insomnia, nervous tension, and anxiety, typically prepared as a root decoction or tincture.
Scientific evidence: The substances found in valerian's volatile oil include valeric acid, bornyl acetate, valeranone, sesquiterpenes, iridoids (valepotriates), alkaloids, furanofuran lignans, and free amino acids like glutamine, tyrosine, arginine, and GABA. The proposed mechanism involves interaction with the GABA system. Plant-based supplements may exert their effects through inhibition of monoamine reuptake (serotonin, dopamine, and norepinephrine), enhanced binding and increased sensitivity of serotonin receptors, and monoamine oxidase inhibition. Other effects may include GABAergic activity, cytokine modulation, and influences on the opioid and endocannabinoid systems. Evidence from clinical trials specifically for valerian on neurotransmitter outcomes remains limited and methodologically inconsistent.
7.5 L-Theanine
L-theanine is an amino acid found predominantly in green tea (Camellia sinensis). It is not synthesized in the human body and is consumed as a food component or supplement.
Scientific evidence: Investigation of whether the sleep-promoting mechanism of GABA/L-theanine mixture mediates neurotransmitter receptor expression changes found that transcript levels for the GABAA receptor following the combined administration of GABA/L-theanine were 1.53-fold higher than control levels. Moreover, GABA/L-theanine combined infusion led to significant changes in the mRNA levels of GABAB-R2 (21.4%). This study was conducted in animal models, and human evidence is still limited. The combination of GABA and L-theanine may synergistically promote symptomatic relief for sleep disorders, despite the scarce experimental data supporting this process.
8. The Gut-Brain Axis and Dietary Modulation
Gut bacteria play an important role in the digestion of food, immune activation, and regulation of entero-endocrine signaling pathways, and also communicate with the central nervous system through the production of specific metabolic compounds including GABA, dopamine, norepinephrine, serotonin, and histamine.
Because neurotransmitters such as glutamate, GABA, dopamine, and serotonin do not penetrate the blood-brain barrier, they must be synthesized in the brain from local pools of neurotransmitter precursors. Most of these precursors are amino acids (e.g., tyrosine and tryptophan) derived from the diet, which enter the blood, are transported across the blood-brain barrier, and are taken up by corresponding neurotransmitter-producing cells.
From a mechanistic perspective, microbial pathways play a vital role in the synthesis and regulation of neurochemicals such as GABA, serotonin, dopamine, and their respective precursors. These metabolites influence receptor expression and CNS signaling, particularly via vagal pathways and modulation of precursor bioavailability. Notably, experimental studies using germ-free animal models have revealed profound shifts in fecal and serum neurotransmitter levels, underscoring the foundational role of microbiota in setting neurochemical baselines.
In humans, preliminary reports suggest that manipulating the human microbiota may impact GABA levels. Dietary interventions are well known for their ability to alter the composition and function of the gut microbiome, and a ketogenic diet was shown to increase GABA levels in the cerebrospinal fluid of children with refractory epilepsy, a response correlated with improvement of symptoms. These findings are promising but require further large-scale human trials.
Key nutritional determinants of serotonergic function include macronutrients that influence the tryptophan-to-large neutral amino acid ratio (a regulator of tryptophan availability in the brain) and micronutrients, such as B-vitamins, vitamin D, iron, and magnesium, that serve as essential cofactors in serotonin synthesis and metabolism. Emerging evidence also highlights the role of the gut microbiota, shaped by dietary components, prebiotics, and probiotics, in modulating serotonergic function across both central and peripheral systems.
9. Dietary and Lifestyle Factors
9.1 Dietary Patterns and Macronutrients
The dietary consumption of amino acids may affect the serotonin-mediated modulation of stress and mood-related affective disorders, and the effect of diet on serotonergic neurotransmission in depression may be relevant. Protein quality and adequacy are therefore foundational, as they determine the availability of amino acid precursors. Nutritional factors that affect serotonin have been increasingly linked to conditions such as depression, anxiety, sleep disturbances, disordered eating, obesity, and irritable bowel syndrome.
9.2 Probiotics and Prebiotics
Therapies influencing the gut microbiota, including probiotics, prebiotics, and fecal microbiota transplant, could help in the treatment of mental illnesses. However, further research is needed to understand the underlying mechanisms and optimize microbiota-targeted interventions for these conditions. Current evidence is largely preliminary, arising from animal models and small human trials.
9.3 Physical Exercise
Regular physical training can modulate the functioning of neurochemical pathways, leading to increased dopaminergic and noradrenergic activity and optimized orexin release, which supports better regulation of circadian rhythms, energy levels, and adaptive capacity to physical exertion. Consuming a nutritious diet, getting regular exercise, and stress management can help in some cases to support appropriate neurotransmitter function.
9.4 Sleep
Neurotransmitters such as acetylcholine, dopamine, norepinephrine, serotonin, histamine, and orexin peptides work together to maintain wakefulness. These mechanisms are particularly important for vigilance, reaction time, motor coordination, and physical performance. Disrupted sleep, in turn, alters these neurochemical pathways, creating a bidirectional relationship between sleep quality and neurotransmitter regulation.
9.5 Stress Management
Chronic physical or emotional stress can be a contributor to neurotransmitter system changes. Chronic stress is typically the primary contributor to neurotransmitter imbalance in vivo. Stress, both emotional and physical, can cause neurons to use up large amounts of neurotransmitters in order to help the person cope with their problems. Psychological and behavioral interventions that reduce allostatic load therefore have indirect but meaningful effects on neurochemical regulation.
9.6 Evidence Limitations Across Dietary and Lifestyle Approaches
There is no proven way to ensure that neurotransmitters are balanced and working correctly. Some people try supplements to boost certain neurotransmitters. In most cases, there is not enough evidence to show they work. Much of the available human evidence is derived from small, short-term randomized controlled trials, observational studies, or animal and in vitro models. Extrapolations to specific dietary interventions should be made with appropriate caution pending larger, well-powered clinical trials.
References
- StatPearls (NCBI): Physiology, Neurotransmitters
- PMC: Neurotransmitters — Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System
- Wikipedia: Neurotransmitter
- PMC: A Comprehensive Review of Nutritional Influences on the Serotonergic System
- PMC: Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis
- PMC: L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications
- PMC: Tryptophan in Nutrition and Health
- PMC: Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders
- PMC: Neurotransmitter Modulation by the Gut Microbiota
- PMC: The Correlation Between Gut Microbiota and Both Neurotransmitters and Mental Disorders
- PMC: Gut Bacteria and Neurotransmitters
- PMC: The Gut Microbiome and Its Impact on Mood and Decision-Making
- PMC: Vitamins and Minerals for Energy, Fatigue and Cognition
- Linus Pauling Institute, Oregon State University: Cognitive Function In Depth
- PMC: Effect of Magnesium and Vitamin B6 Supplementation on Mental Health and Quality of Life in Stressed Healthy Adults
- PubMed: Current St John's Wort Research from Mode of Action to Clinical Efficacy
- MDPI: Review of Case Study Results — Curcumin, St. John's Wort, Valerian Root, Milk Thistle, and Ashwagandha in OCD
- MDPI Pharmaceuticals: Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action
- PMC: GABA and L-Theanine Mixture Decreases Sleep Latency and Improves NREM Sleep
- PMC: Neurotransmitters Regulation and Food Intake: The Role of Dietary Sources in Neurotransmission
- PMC: N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems
- PMC: The Effects of Omega-3 Supplementation Combined with Strength Training on Neuro-Biomarkers
- PMC: Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild-to-Moderate Anxiety
- PMC: From Mood to Memory — Unlocking Saffron's Potential in Brain Health
- PMC: Exploring the Potential of Saffron as a Therapeutic Agent in Depression Treatment
- PMC: Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults
- PMC: Effectivity of Saffron Extract on Treatment for Children and Adolescents with ADHD
- PMC: Saffron and Its Active Ingredients Against Human Disorders
- Medical News Today: Neurotransmitters — What They Are, Functions, and Psychology
- Cleveland Clinic: Neurotransmitters — What They Are, Functions and Types
- PMC: Neurobiological Synergy of Plant and Animal Sources of Omega-3 and Exercise in Aging
- PMC: Sleep and Athletic Performance — A Multidimensional Review of Physiological and Molecular Mechanisms
Go back